Development and characterization of alginate coated low molecular weight chitosan nanoparticles as new carriers for oral vaccine delivery in mice

Carbohydrate Polymers

Volumn 121, Issue , 2015, Pages 403-410

  Biswas, Subrata ^a   Chattopadhyay, Mainak ^b   Sen, Kalyan Kumar ^c   Saha, Malay Kumar ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b Bengal School of Technology   (India)

^c GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL CULTURE; CHITOSAN; MAMMALS; NANOPARTICLES; SODIUM ALGINATE; VACCINES;

ACIDIC CONDITIONS; COATED NANOPARTICLES; EXTENDED RELEASE; IMMUNOLOGICAL RESPONSE; LOW CYTOTOXICITIES; LOW MOLECULAR WEIGHT CHITOSANS; MUCOSAL IMMUNE RESPONSE; SUSTAINED RELEASE KINETICS;

IMMUNE SYSTEM;

MUS;

ALGINIC ACID; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACID; MEASLES VACCINE; NANOPARTICLE;

ANIMAL; CHEMISTRY; HT 29 CELL LINE; HUMAN; MOLECULAR WEIGHT; MOUSE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACIDS; HT29 CELLS; HUMANS; MEASLES VACCINE; MICE; MOLECULAR WEIGHT; NANOPARTICLES;

EID: 84921047054     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.12.044     Document Type: Article

References (45)

1. Z. Amoozgar, J. Park, Q. Lin, and Y. Yeo Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery Molecular Pharmaceutics 9 2012 1262 1270
2. A.K. Anal, D. Bhopatkar, S. Tokura, H. Tamura, and W.F. Stevens Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein Drug Development and Industrial Pharmacy 29 2003 713 724
3. U. Baumann Mucosal vaccination against bacterial respiratory infections Expert Review Vaccines 7 2008 1257 1276
4. O. Borges, A. Cordeiro-da-Silva, S.G. Romeijn, M. Amidi, A. de Sousa, and G. Borchard Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination Journal of Controlled Release 114 2006 348 358
5. O. Borges, M. Silva, A. de Sousa, G. Borchard, H.E. Junginger, and A. Cordeiro-da-Silva Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen International Immunopharmacology 8 2008 1773 1780
6. O. Borges, J. Tavares, A. de Sousa, G. Borchard, H.E. Junginger, and A. Cordeiro-da-Silva Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles European Journal of Pharmaceutical Sciences 32 2007 278 290
7. P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, and M.J. Alonso Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines Pharmaceutical Research 14 1997 1431 1436
8. F. Chen, Z.R. Zhang, and Y. Huang Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers International Journal of Pharmaceutics 336 2007 166 173
9. P. Costa, and J.M. Sousa Lobo Evaluation of mathematical models describing drug release from estradiol transdermal systems Drug Development and Industrial Pharmacy 29 2003 89 97
10. N. Csaba, M. Koping-Hoggard, and M.J. Alonso Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery International Journal of Pharmaceutics 382 2009 205 214
11. C. Czerkinsky, and J. Holmgren Enteric vaccines for the developing world: A challenge for mucosal immunology Mucosal Immunology 2 2009 284 287
12. F. Delie, and M.J. Blanco-Prieto Polymeric particulates to improve oral bioavailability of peptide drugs Molecules 10 2005 65 80
13. C. Du, J. Zhao, J. Fei, L. Gao, W. Cui, and Y. Yang Alginate-based microcapsules with a molecule recognition linker and photosensitizer for the combined cancer treatment Chemistry - An Asian Journal 8 2013 736 742
14. J.E. Eyles, G.J. Sharp, E.D. Williamson, I.D. Spiers, and H.O. Alpar Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse Vaccine 16 1998 698 707
15. J.C. Fernandes, X. Qiu, F.M. Winnik, M. Benderdour, X. Zhang, and K. Dai Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: Optimization studies International Journal of Nanomedicine 7 2012 5833 5845
16. A.R. Fooks Development of oral vaccines for human use Current Opinion in Molecular Therapeutics 2 2004 80 86
17. Q. Gan, T. Wang, C. Cochrane, and P. McCarron Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery Colloids and Surface B: Biointerfaces 44 2005 65 73
18. T. Gazori, M.R. Khoshayand, E. Azizi, P. Yazdizade, A. Nomani, and I. Haririan Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: Formulation, optimization and in vitro characterization Carbohydrate Polymers 77 2009 599 606
19. W.T. Godbey, K.K. Wu, and A.G. Mikos Size matters: Molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle Journal of Biomedical Material Research 45 1999 268 275
20. J. Hoff Methods of blood collection in the lab mouse Laboratory Animals 29 2000 49 53
21. M. Huang, E. Khor, and L.Y. Lim Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation Pharmaceutical Research 21 2004 344 353
22. B. Kim, T. Bowersock, P. Griebel, A. Kidane, L.A. Babiuk, and M. Sanchez Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres Journal of Controlled Release 85 2002 191 202
23. S.H. Kim, K.Y. Lee, and Y.S. Jang Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination Immune Network 12 2012 165 175
24. A. Kostrzak, M. Cervantes Gonzalez, D. Guetard, D.B. Nagaraju, S. Wain-Hobson, and D. Tepfer Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells Vaccine 27 2009 4798 4807
25. M. Lavertu, S. Methot, N. Tran-Khanh, and M.D. Buschmann High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation Biomaterials 27 2006 4815 4824
26. E. Lee, J. Lee, and S. Jon A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan Bioconjugate Chemistry 21 2010 1720 1723
27. S.J. Lee, H. Koo, H. Jeong, M.S. Huh, Y. Choi, and S.Y. Jeong Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy Journal of Controlled Release 152 2011 21 29
28. X. Li, X. Kong, S. Shi, X. Zheng, G. Guo, and Y. Wei Preparation of alginate coated chitosan microparticles for vaccine delivery BMC Biotechnology 8 2008 89
29. Z. Liu, D. Lv, S. Liu, J. Gong, D. Wang, and M. Xiong Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: Effect against breast cancer in mice PLoS ONE 8 2013 e60190
30. B. Malik, A.K. Goyal, F. Zakir, and S.P. Vyas Surface engineered nanoparticles for oral immunization Journal of Biomedical Nanotechnology 7 2011 132 134
31. S. Mao, X. Shuai, F. Unger, M. Simon, D. Bi, and T. Kissel The depolymerization of chitosan: Effects on physicochemical and biological properties International Journal of Pharmaceutics 281 2004 45 54
32. T. Mosmann Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays Journal of Immunological Methods 65 1983 55 63
33. M.R. Neutra, and P.A. Kozlowski Mucosal vaccines: The promise and the challenge Nature Reviews Immunology 6 2006 148 158
34. C.R. Oliveira, C.M. Rezende, M.R. Silva, A.P. Pego, O. Borges, and A.M. Goes A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis PLoS Neglected Tropical Diseases 6 2012 e1894
35. P. Opanasopit, P. Aumklad, J. Kowapradit, T. Ngawhiranpat, A. ApirakaraM. Wong, and T. Rojanarata Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2) Pharmaceutical Development and Technology 12 2007 447 455
36. S.C. Richardson, H.V. Kolbe, and R. Duncan Potential of low molecular mass chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA International Journal of Pharmaceutics 178 1999 231 243
37. 2 on human epithelial intestinal HT-29 cell line The Annals of Occupational Hygiene 56 2012 622 630
38. M.K. Song, C.J. Vindurampulle, A.V. Capozzo, J. Ulmer, J.M. Polo, and M.F. Pasetti Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins Journal of Virology 79 2005 9854 9861
39. S.M. van der Merwe, J.C. Verhoef, J.H. Verheijden, A.F. Kotze, and H.E. Junginger Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs European Journal of Pharmaceutics and Biopharmacutics 58 2004 225 235
40. A. Vila, A. Sanchez, K. Janes, I. Behrens, T. Kissel, and J.L. Vila Jato Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice European Journal of Pharmaceutics and Biopharmaceutics 57 2004 123 131
41. S. Wee, and W.R. Gombotz Protein release from alginate matrices Advanced Drug Delivery Reviews 31 1998 267 285
42. Y. Yang, Q. He, L. Duan, Y. Cui, and J. Li Assembled alginate/chitosan nanotubes for biological application Biomaterials 28 2007 3083 3090
43. M.K. Yoo, S.K. Kang, J.H. Choi, I.K. Park, H.S. Na, and H.C. Lee Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique Biomaterials 31 2010 7738 7747
44. D.A. Zaharoff, C.J. Rogers, K.W. Hance, J. Schlom, and J.W. Greiner Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination Vaccine 25 2007 2085 2094
45. Q. Zhu, and J.A. Berzofsky Oral vaccines: Directed safe passage to the front line of defense Gut Microbes 4 2013 246 252